Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · Real-Time Price · USD
2.320
+0.020 (0.87%)
At close: Jun 26, 2026, 4:00 PM EDT
2.400
+0.080 (3.45%)
After-hours: Jun 26, 2026, 6:51 PM EDT
Century Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Century Therapeutics stock have an average target of 5.90, with a low estimate of 4.00 and a high estimate of 8.00. The average target predicts an increase of 154.31% from the current stock price of 2.32.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Century Therapeutics stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 1 | 2 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 3 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho Securities | Mizuho Securities | Buy Maintains $8 | Buy | Maintains | $8 | +244.83% | Jun 10, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 9, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $4 | Buy | Reiterates | $4 | +72.41% | Jun 9, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $5 | Buy | Reiterates | $5 | +115.52% | May 26, 2026 |
| Clear Street | Clear Street | Buy Maintains $6.6 | Buy | Maintains | $6.6 | +184.48% | Mar 12, 2026 |
Financial Forecast
Revenue This Year
n/a
from 109.16M
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-0.46
from -0.03
EPS Next Year
-0.46
from -0.46
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -100.0% | - | |
| Avg | -100.0% | - | |
| Low | -100.0% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.37 | -0.28 | |
| Avg | -0.46 | -0.46 | |
| Low | -0.55 | -0.56 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.